Organosynth Chemicals And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 2 Year, 8 Months
About Organosynth Chemicals And Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nitin Ligde, Vivek Grover, Pardeep Sethi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290MH2022PTC380512
- Company No.
380512
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2022
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Organosynth Chemicals And Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushilkumar Bahekar  | Director | 13-Apr-2022 | Current |
| Nitin Ligde | Director | 13-Apr-2022 | Current |
| Vivek Grover | Director | 13-Apr-2022 | Current |
Pardeep Sethi  | Director | 13-Apr-2022 | Current |
Financial Performance of Organosynth Chemicals And Pharmaceuticals.
Enhance accessibility to Organosynth Chemicals And Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Organosynth Chemicals And Pharmaceuticals?
Unlock access to Organosynth Chemicals And Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ria International India Private LimitedActive 13 years 3 monthsVivek Grover and Pardeep Sethi are mutual person
- Shree Chatrapati Sambhajinagar Chemical Technology Alumni AssociationActive 1 year 6 months
Sushilkumar Bahekar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Organosynth Chemicals And Pharmaceuticals?
Organosynth Chemicals And Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Organosynth Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Organosynth Chemicals And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
